23 research outputs found

    The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study.

    Get PDF
    BACKGROUND: The introduction of a conjugate vaccine for serogroup A Neisseria meningitidis has dramatically reduced disease in the African meningitis belt. In this context, important questions remain about the performance of different vaccine policies that target remaining serogroups. Here, we estimate the health impact and cost associated with several alternative vaccination policies in Burkina Faso. METHODS AND FINDINGS: We developed and calibrated a mathematical model of meningococcal transmission to project the disability-adjusted life years (DALYs) averted and costs associated with the current Base policy (serogroup A conjugate vaccination at 9 months, as part of the Expanded Program on Immunization [EPI], plus district-specific reactive vaccination campaigns using polyvalent meningococcal polysaccharide [PMP] vaccine in response to outbreaks) and three alternative policies: (1) Base Prime: novel polyvalent meningococcal conjugate (PMC) vaccine replaces the serogroup A conjugate in EPI and is also used in reactive campaigns; (2) Prevention 1: PMC used in EPI and in a nationwide catch-up campaign for 1-18-year-olds; and (3) Prevention 2: Prevention 1, except the nationwide campaign includes individuals up to 29 years old. Over a 30-year simulation period, Prevention 2 would avert 78% of the meningococcal cases (95% prediction interval: 63%-90%) expected under the Base policy if serogroup A is not replaced by remaining serogroups after elimination, and would avert 87% (77%-93%) of meningococcal cases if complete strain replacement occurs. Compared to the Base policy and at the PMC vaccine price of US4perdose,strategiesthatusePMCvaccine(i.e.,BasePrimeandPreventions1and2)areexpectedtobecostsavingifstrainreplacementoccurs,andwouldcostUS4 per dose, strategies that use PMC vaccine (i.e., Base Prime and Preventions 1 and 2) are expected to be cost saving if strain replacement occurs, and would cost US51 (-US236,US236, US490), US188(−US188 (-US97, US626),andUS626), and US246 (-US53,US53, US703) per DALY averted, respectively, if strain replacement does not occur. An important potential limitation of our study is the simplifying assumption that all circulating meningococcal serogroups can be aggregated into a single group; while this assumption is critical for model tractability, it would compromise the insights derived from our model if the effectiveness of the vaccine differs markedly between serogroups or if there are complex between-serogroup interactions that influence the frequency and magnitude of future meningitis epidemics. CONCLUSIONS: Our results suggest that a vaccination strategy that includes a catch-up nationwide immunization campaign in young adults with a PMC vaccine and the addition of this new vaccine into EPI is cost-effective and would avert a substantial portion of meningococcal cases expected under the current World Health Organization-recommended strategy of reactive vaccination. This analysis is limited to Burkina Faso and assumes that polyvalent vaccines offer equal protection against all meningococcal serogroups; further studies are needed to evaluate the robustness of this assumption and applicability for other countries in the meningitis belt

    La méningite, une maladie des « variations » : pratiques préventives et gestion des épidémies de méningite à Kombissiri et Réo Burkina Faso

    No full text
    Meningitis is an epidemic whose management requires as well medical techniques as social behaviors’. Burkina Faso remains one of the countries of Africa more touched by meningitis. Between 1988 and 1997, WHO counts there more than 700,000 cases and 70,000 deaths, without counting the neurological victims of meningitis sequelae are difficult to evaluate. The objective of this work is to study the social representations of meningitis and the preventive practices which can contribute to increase the rates of morbidity and mortality.We conducted a socioanthropologic study in Kombissiri (moose’s country) and Reo (lyele’s country) in Burkina Faso. We make individual interviews with tradipraticians, traditional leaders, religious leaders, administrative authorities and health workers. Focus group was made with women, men, pupils and the young people.The results show that actors have knowledge of meningitis : symptomatic descriptions, period of appearance, transmission systems and meningitis sequelae (deafness, stammering, loss of memory, eye trouble). So formerly the stiffness of the neck and the appearance in period of strong hot made conspicuous meningitis, according to the popular designs, the etiologies and the diffuse symptomatic demonstrations of the preventive measures, popular perceptions (perceptions regarding meningitis in local populations) and diagnosis are complex

    La méningite, une maladie des « variations » : pratiques préventives et gestion des épidémies de méningite à Kombissiri et Réo Burkina Faso

    No full text
    Meningitis is an epidemic whose management requires as well medical techniques as social behaviors’. Burkina Faso remains one of the countries of Africa more touched by meningitis. Between 1988 and 1997, WHO counts there more than 700,000 cases and 70,000 deaths, without counting the neurological victims of meningitis sequelae are difficult to evaluate. The objective of this work is to study the social representations of meningitis and the preventive practices which can contribute to increase the rates of morbidity and mortality.We conducted a socioanthropologic study in Kombissiri (moose’s country) and Reo (lyele’s country) in Burkina Faso. We make individual interviews with tradipraticians, traditional leaders, religious leaders, administrative authorities and health workers. Focus group was made with women, men, pupils and the young people.The results show that actors have knowledge of meningitis : symptomatic descriptions, period of appearance, transmission systems and meningitis sequelae (deafness, stammering, loss of memory, eye trouble). So formerly the stiffness of the neck and the appearance in period of strong hot made conspicuous meningitis, according to the popular designs, the etiologies and the diffuse symptomatic demonstrations of the preventive measures, popular perceptions (perceptions regarding meningitis in local populations) and diagnosis are complex

    Financial Sustainability of Immunization Programs in sub-Saharan Africa

    No full text
    The introduction of new vaccines with much higher prices than traditional vaccines results in increas-ing budgetary pressure on immunization programs in GAVI-eligible countries, increasing the need toensure their financial sustainability. In this context, the third EPIVAC (Epidemiology and Vaccinology)technical conference was held from February 16 to 18, 2012 at the Regional Institute of Public Healthin Ouidah, Benin. Managers of ministries of health and finance from 11 West African countries (GAVIeligible countries), as well as former EPIVAC students and European experts, shared their knowledge andbest practices on immunization financing at district and country level.The conference concluded by stressing five major priorities for the financial sustainability of nationalimmunization programs (NIPs) in GAVI-eligible countries

    The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study.

    No full text
    BACKGROUND:The introduction of a conjugate vaccine for serogroup A Neisseria meningitidis has dramatically reduced disease in the African meningitis belt. In this context, important questions remain about the performance of different vaccine policies that target remaining serogroups. Here, we estimate the health impact and cost associated with several alternative vaccination policies in Burkina Faso. METHODS AND FINDINGS:We developed and calibrated a mathematical model of meningococcal transmission to project the disability-adjusted life years (DALYs) averted and costs associated with the current Base policy (serogroup A conjugate vaccination at 9 months, as part of the Expanded Program on Immunization [EPI], plus district-specific reactive vaccination campaigns using polyvalent meningococcal polysaccharide [PMP] vaccine in response to outbreaks) and three alternative policies: (1) Base Prime: novel polyvalent meningococcal conjugate (PMC) vaccine replaces the serogroup A conjugate in EPI and is also used in reactive campaigns; (2) Prevention 1: PMC used in EPI and in a nationwide catch-up campaign for 1-18-year-olds; and (3) Prevention 2: Prevention 1, except the nationwide campaign includes individuals up to 29 years old. Over a 30-year simulation period, Prevention 2 would avert 78% of the meningococcal cases (95% prediction interval: 63%-90%) expected under the Base policy if serogroup A is not replaced by remaining serogroups after elimination, and would avert 87% (77%-93%) of meningococcal cases if complete strain replacement occurs. Compared to the Base policy and at the PMC vaccine price of US4perdose,strategiesthatusePMCvaccine(i.e.,BasePrimeandPreventions1and2)areexpectedtobecostsavingifstrainreplacementoccurs,andwouldcostUS4 per dose, strategies that use PMC vaccine (i.e., Base Prime and Preventions 1 and 2) are expected to be cost saving if strain replacement occurs, and would cost US51 (-US236,US236, US490), US188(−US188 (-US97, US626),andUS626), and US246 (-US53,US53, US703) per DALY averted, respectively, if strain replacement does not occur. An important potential limitation of our study is the simplifying assumption that all circulating meningococcal serogroups can be aggregated into a single group; while this assumption is critical for model tractability, it would compromise the insights derived from our model if the effectiveness of the vaccine differs markedly between serogroups or if there are complex between-serogroup interactions that influence the frequency and magnitude of future meningitis epidemics. CONCLUSIONS:Our results suggest that a vaccination strategy that includes a catch-up nationwide immunization campaign in young adults with a PMC vaccine and the addition of this new vaccine into EPI is cost-effective and would avert a substantial portion of meningococcal cases expected under the current World Health Organization-recommended strategy of reactive vaccination. This analysis is limited to Burkina Faso and assumes that polyvalent vaccines offer equal protection against all meningococcal serogroups; further studies are needed to evaluate the robustness of this assumption and applicability for other countries in the meningitis belt

    The actual and potential costs of meningitis surveillance in the African meningitis belt: Results from Chad and Niger.

    No full text
    BACKGROUND: The introduction of serogroup A meningococcal conjugate vaccine in the African meningitis belt required strengthened surveillance to assess long-term vaccine impact. The costs of implementing this strengthening had not been assessed. METHODOLOGY: The ingredients approach was used to retrospectively determine bacterial meningitis surveillance costs in Chad and Niger in 2012. Resource use and unit cost data were collected through interviews with staff at health facilities, laboratories, government offices and international partners, and by reviewing financial reports. Sample costs were extrapolated to national level and costs of upgrading to desired standards were estimated. RESULTS: Case-based surveillance had been implemented in all 12 surveyed hospitals and 29 of 33 surveyed clinics in Niger, compared to six out of 21 clinics surveyed in Chad. Lumbar punctures were performed in 100% of hospitals and clinics in Niger, compared to 52% of the clinics in Chad. The total costs of meningitis surveillance were US1,951,562inNigerandUS 1,951,562 in Niger and US 338,056 in Chad, with costs per capita of US0.12andUS 0.12 and US 0.03, respectively. Laboratory investigation was the largest cost component per surveillance functions, comprising 51% of the total costs in Niger and 40% in Chad. Personnel resources comprised the biggest expense type: 37% of total costs in Niger and 26% in Chad. The estimated annual, incremental costs of upgrading current systems to desired standards were US183,299inNigerandUS 183,299 in Niger and US 605,912 in Chad, which are 9% and 143% of present costs, respectively. CONCLUSIONS: Niger's more robust meningitis surveillance system costs four times more per capita than the system in Chad. Since Chad spends less per capita, fewer activities are performed, which weakens detection and analysis of cases. Countries in the meningitis belt are diverse, and can use these results to assess local costs for adapting surveillance systems to monitor vaccine impact

    The proposed model matches the key characteristics of meningitis epidemics in Burkina Faso observed between 2002 and 2015.

    No full text
    <p>(A) Age distribution of probable meningococcal meningitis in Burkina Faso from 2007–2011 [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1002495#pmed.1002495.ref011" target="_blank">11</a>] versus the age distribution of cases generated by the model. (B) Estimated meningococcal carriage prevalence in different age groups from carriage survey studies in the African meningitis belt [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1002495#pmed.1002495.ref034" target="_blank">34</a>] versus the age-specific average carriage prevalence obtained from the model. (C–D) Average and standard deviation of weekly clinical meningitis cases observed from 2002–2015 versus those produced by the model. (E) Cosine of the angle (<b><i>θ</i></b>) between the vectors of Fourier amplitude for observed and simulated meningitis time series (cosine of 1 indicates total match in periodicity and cosine of 0 indicates no overlap between the significant periods of two time series; see <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1002495#pmed.1002495.s001" target="_blank">S1 Text</a> for additional details). (F) Observed (Data) and simulated (Model) number of districts in each year between 2002 and 2015 in which the threshold of 10 meningitis cases per 100,000 population was exceeded. Cos, cosine; StDev, standard deviation.</p
    corecore